Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00242229 |
To evaluate the overall safety and tolerability profile of two dose levels of DVS-233 SR during 6 months of open-label treatment in elderly outpatients with major depressive disorder.
Condition | Intervention |
---|---|
Major Depressive Disorder |
Drug: DVS-233 SR |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | A 6 Month, Open-Label Evaluation of the Long-Term Safety of DVS-233 SR in Elderly Outpatients With Major Depressive Disorder (MDD) |
Estimated Enrollment: | 75 |
Study Start Date: | October 2004 |
Estimated Study Completion Date: | October 2005 |
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Other exclusion applies.
Study ID Numbers: | 3151A1-307 |
Study First Received: | October 17, 2005 |
Last Updated: | May 18, 2006 |
ClinicalTrials.gov Identifier: | NCT00242229 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Depression |
Depression Mental Disorders Mood Disorders |
Depressive Disorder, Major Depressive Disorder Behavioral Symptoms |
Pathologic Processes Disease Depression Mental Disorders |
Mood Disorders Depressive Disorder, Major Depressive Disorder Behavioral Symptoms |